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Background
There is accumulating evidence that polyfunctional T
cells, effector T cells capable of simultaneously produ-
cing multiple pro-inflammatory cytokines, are more effi-
cacious in controlling infection and cancer. However,
how polyfunctional CD4+ effector cells are induced is
not mechanistically understood.
Results
In this study we established that IL7 can promote the
acquisition of polyfunctionality in naïve CD4+ T cells
upon antigenic stimulation in vitro. In particular, IL7-
conditioned polyfunctional CD4+ T cells can concomi-
tantly express IFN-g, TNF-a, IL-2 and granzyme B, with
a separate IL4-producing population. We demonstrated
that IL7 signaling resulted in increased histone acetyla-
tion in the promoters of effector molecules including
IFN-g, TNF-Αalpha, IL-2 and granzyme B, but not in
Foxp3 and PD1, suggesting a selective enhancement in
chromatin accessibility.
Mechanistically, STAT5 is required for IL7-driven
polyfunctionality as expression of constitutive active
STAT5 mutant in CD4+ T cells conferred polyfunction-
ality to CD4+ T cells even in the absence of IL7,
whereas expression of dominant negative STAT5 mutant
abolished IL7-driven polyfunctionality. Surprisingly, fully
armed polyfunctional CD4+ T cells did not exhibit potent
anti-tumor effect when adoptively transferred into mice
with established B cell lymphoma, suggesting the domi-
nance of immune suppression in the tumor microenviron-
ment. Durable curative anti-tumor effect can be achieved
by providing TriVax, a vaccine consisting of peptide, poly-
IC adjuvant and OX40 antibody, following polyfunctional
CD4+ T cell transfer.
Conclusions
Our results provide novel insights into the generation of
polyfunctional CD4+ effector cells and their potential
usage in cancer immunotherapy.
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